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Abstract: Background: Nutrient-sensing receptors located on enteroendocrine (EEC) cells modulate
appetite via detection of luminal contents. Colonic ‘tasting’ of luminal contents may influence
changes to appetite observed in obesity and after weight loss induced by bariatric surgery.
We assessed the effects of obesity and gastric bypass-induced weight loss on expression of
nutrient-sensing G-protein coupled receptors (GPCRs), EEC and enterochromaffin (EC) cells and
mucosal innervation. Methods: qPCR and immunohistochemistry were used to study colonic
tissue from (a) chow-fed/lean, (b) high-fat fed/obese, (c) Roux-en-Y gastric bypass surgery (RYGB),
and (d) calorie restriction-induced weight loss mice. Results: Expression of GPR41, GPR43,
GPR40, GPR120, GPR84, GPR119, GPR93 and T1R3 was increased in obese mice. Obesity-induced
overexpression of GPR41, 40, 84, and 119 further increased after RYGB whereas GPR120 and T1R3
decreased. RYGB increased TGR5 expression. L-cells, but not EC cells, were increased after RYGB.
No differences in mucosal innervation by protein gene product (PGP) 9.5 and GLP-1R-positive nerve
fibers were observed. Stimulation of colonic mucosa with GPR41, GPR40, GPR85, GPR119, and TGR5
agonists increased cell activation marker expression. Conclusions: Several nutrient-sensing receptors
induced activation of colonic EEC. Profound adaptive changes to the expression of these receptors
occur in response to diet and weight loss induced by RYGB or calorie restriction.
Keywords: enteroendocrine cells (EECs); appetite regulation; Roux-en-Y gastric bypass (RYGB);
weight loss
1. Introduction
We have previously shown that nutrient-sensing g-protein coupled receptors (GPCRs) are
found throughout the gastrointestinal tract (GIT), with colonic expression concentration amongst
the highest [1]. Nutrient-sensing GPCRs respond to luminal dietary contents including amino acids
(AAs), peptides, short-chain fatty acids (SCFAs), medium-chain fatty acids (MCFAs), long-chain fatty
acids (LCFAs), lipid metabolites, and bile acids [2]. Importantly, many of these receptors, including
GPR41 and GPR43 (SCFA sensors), GPR84 and GPR40 (MCFA sensors), GPR120 (MCFA/LCFA),
and GPR119 (lipid metabolite sensors), are expressed on L-cells and enterochromaffin (EC) cells.
Indeed, activation of human colonic GPCRs, such as calcium-sensing receptors (CaSR) and GPR84,
induce the release of 5-HT from EC cells, and glucagon-like peptide (GLP-1) and PYY from L-cells [1].
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Therefore, the activation of enteroendocrine (EEC) and EC cells is dependent on the expression and
ligand-induced activation of nutrient-sensing GPCRs. We explored the concept that changes in the
luminal content, e.g., normal diet vs. high-fat vs. undigested nutrients (shunted to the colon as in
RYGB), may dynamically alter the type and number of GPCRs, which alters the function of the cells on
which they are expressed.
Roux-en-Y gastric bypass (RYGB) is a form of bariatric surgery that has a high level of success with
patients consistently losing weight, normalizing insulin sensitivity, and changing eating habits [3–5].
These are complex and multifactorial changes that are yet to be completely understood at the molecular
level. However, clinical studies have shown that significantly increased postprandial circulation levels
of the anorectic and incretin hormones PYY and GLP-1 are likely to be important factors in appetite
reduction following RYGB [6]. L-cells are expressed throughout the gut with the highest density
found in the colon [7,8]. Therefore, enteroendocrine (EEC) cells in the colon, such as L-cells, are likely
important contributors to decreased appetite and food intake following RYGB. This may reflect the
ability of the cell to respond to the luminal environment and to sense specific nutrients. In obesity,
overall L-cell number decreases, as does the ability of these cells to release GLP-1 [9], suggesting a
high-fat diet reduces cell activation. Additionally, 5-HT released from EC cells is likely to have an
important role in modulating appetite as nutrients stimulate the release of 5-HT to activate duodenal
vagal afferent fibers [10]. Therefore, colonic 5-HT release stimulated by dietary nutrients may have a
similar effect on colonic vagal afferents which act on 5-HT3 receptors [11]. Collectively, the activation
and release of hormones/transmitters from L-cells and EC cells are critical pathways, and thus it is
important to elucidate the mechanisms by which these cells are activated after RYGB treatment.
The aims of this study were to specifically characterize changes to colonic mucosa resulting from
exposure to changing luminal contents from a normal nutrient load to a high-calorific load, and to the
arrival of undigested food shunted to colon after RYGB treatment. Changes to mRNA expression of
nutrient-sensing GPCRs and mediator hormones/peptides, EECs, EC cell population, and neuronal
innervation were assessed before a nutritional challenge was given to naïve colons of normal-weight
mice to observe the effect on the activation of intracellular pathways. The results of this study will
have relevance for the development of non-surgical, luminally-acting treatments for obesity.
2. Materials and Methods
2.1. Animals
Male C57/BL6J mice were purchased from Jackson Laboratories and individually housed at the
Pennington Biomedical Research Center Vivarium in wire mesh cages in climate-controlled rooms
(21–23 ◦C, lights on at 07:00 h, lights off at 19:00 h). Mice were exposed to a high-fat diet (60% energy
from fat, Research Diets # 12492) for 12–14 weeks before and 12 weeks after surgery (see below),
when tissues were harvested. Animals of the weight-matched group were given ~93% of total restricted
calories as high-fat and ~7% as regular chow. An additional group of age-matched mice was exposed
to low-fat regular chow diet (#5001, Purina, St. Louis, MO, USA). Animal care and experimentation
was approved by the Pennington Biomedical Research Center Institutional Animal Care and Use
Committee and strictly followed rules and guidelines provided by the American Physiological Society
and NIH.
A separate cohort of lean non-surgery male C57/BL6J mice at 10 weeks of age was purchased
from Jackson Laboratories and fed a standard lab chow. Colons isolated from these animals were used
in Ussing chamber studies.
2.2. RYGB Surgery
Details of our RYGB surgical procedure were reported previously [12]. Briefly, it consisted of a
very small gastric pouch, a 5–6 cm long Roux-limb, a 4–5 cm long biliopancreatic limb, and a 10–12 cm
long common limb.
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2.3. Experimental Overview
After exposure to a high-fat diet for 12–14 weeks, mice weighed an average of 41.5 g and were
randomly assigned to one of 3 groups: Sham-surgery (obese for the duration of the study), RYGB,
and weight-matching to RYGB by calorie restriction. In addition, a fourth group of age-matched
mice fed a low-fat diet without surgery was included in the same experimental protocol. Food intake
was measured every 1–5 days and body composition every 2 weeks, and energy expenditure and
locomotor activity were measured in metabolic chambers at 2–3 weeks and 8–9 weeks after surgery.
At 12 weeks after surgery, mice were humanely killed, and tissues were harvested. Body weight,
body composition, food intake, energy expenditure, and metabolic blood parameters were published
in a separate paper [13].
2.4. Gene Expression Studies
Quantitative real-time reverse transcriptase PCR (RT-PCR) was used to assess the relative
expression of nutrient GPCRs in human and mouse colonic tissues. Regional expression of the
gastrointestinal (GI) appetite hormones PYY and glucagon (GCG), and TPH-1, an enzyme required
for serotonin synthesis, was also determined. RNA was extracted from tissues using an RNeasy
Mini kit (Qiagen, Hilden, Germany). RNA quantity and quality were assessed using a NanoDrop,
and cDNA was obtained using a High-Capacity cDNA Reverse Transcription Kit with an RNase
inhibitor. RT-PCR was performed using Taqman® array cards pre-loaded with inventoried Taqman®
expression assays (Qiagen). Total target gene expression was determined relative to 18s expression,
as previously described [1].
2.5. Immunohistochemistry
L-cells and EC cells were immunolabeled using antibodies against GLP-1 (1:200, SC-7782 Santa
Cruz Biotechnology, Dallas, TX, USA) and 5-HT (1:400, ab66047 Abcam, Cambridge, UK), respectively.
Neuronal innervation was assessed using pan-neuronal markers, protein gene product (PGP) 9.5
(1:800, 7863-0504 AbD Serotec), and the GLP-1 receptor (1:400, AGR-021 Alomone Labs). Staining
for pERK (1:200, 4370 Cell Signalling, Danvers, MA, USA) and pCamKII (1:200, ab171095 Abcam)
was performed following Ussing chamber experiments. Briefly, 10 µm sections were washed with
blocking buffer. The primary antibody was applied (19 h, 4 ◦C), and tissues were washed with
phosphate-buffered saline (PBS) and incubated (60 min, room temperature) with species-specific
Alexa Fluor-conjugated secondary antibodies (1:200, Invitrogen, Carlsbad, CA, USA). A Leica DM4000
epifluorescence microscope was used to visualize immunoreactivity (IR) and images captured with a
QImaging camera. Immunopositive cells for each group were manually counted in each section and
averaged over five fields of view, as previously described [1]. Neuronal labeling was quantified using
ImageJ software, where five fields of view (1.44 megapixel) were analyzed with ImageJ for the total
number of immunoreactive pixels in the region of interest within the mucosal layer.
2.6. Ussing Chamber Experiments
As previously described, mouse colonic mucosae were divided into three 1 × 1 cm segments,
and each segment was mounted in an Ussing flux chamber. The luminal surface was exposed
to 10 mL nutrient solution, while the basolateral surface was exposed to 10 mL Krebs solution
for 20 min. All solutions were carbogenated at 35–37 ◦C. Colonic mucosa was then fixed in 4%
paraformaldehyde overnight.
2.7. Nutrient Solutions
The luminal side of the mouse colonic mucosa was exposed to a combination of GPR84 agonist
lauric acid (25 mmol/L), GPR119 agonist PSN 375963 (10 µM, Tocris Bioscience, Bristol, UK),
GPR40 agonist AS 2034178 (10 µM, Tocris Bioscience, UK) and TGR5 agonist TS-G 1005 (10 nM,
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Tocris Bioscience, UK). These were made up in Krebs solution: 124.05 mM NaCl (Sigma-Aldrich, UK),
4.78 mM KCl (AnalR UK), 1.33 mM NaH2PO4 (Sigma-Aldrich, UK), 2.44 mM MgSO4 (Sigma-Aldrich,
UK), 2.50 CaCl2, 5.50 mM D-glucose (Sigma-Aldrich, UK), and 25.00 mM NaHCO3 (Sigma-Aldrich,
UK) and carbogenated with 95% O2 and 5% CO2.
2.8. Statistical Analysis
All data are presented as mean ± SEM. The Student’s t-test was used for comparison between
chow and sham groups. For comparisons between four study groups, one-way ANOVA was
used, followed by Bonferroni-corrected multiple comparisons throughout. A p value of > 0.05 was
considered significant.
3. Results
3.1. Obesity-Induced Up-Regulation of Colonic Nutrient-Sensing Receptors
Colonic mRNA expression of nutrient-sensing receptors in obese mice was generally up-regulated
compared to chow-fed lean mice. This up-regulation was statistically significant for short-chain fatty
acid (SCFA) receptors GPR41 and GPR43, medium/long-chain fatty acid (M/LCFA) receptors GPR40,
GPR84, and GPR120, lipid metabolite sensor GPR119, and bile acid-sensing receptor TGR5 (Figure 1).
mRNA levels of T1R3, SGLT1, and GPR92 were not significantly different between chow and obese
groups (Figure 1), although there was a trend towards increased expression, suggesting an overall
increase in nutrient sensing.
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restriction. The expression of SCFA receptor GPR41 was significantly increased in the RYGB group 
compared to chow (lean) and sham operation (obese) (Figure 2A). However, mRNA expression of 
GPR43, another SCFA sensing receptor, increased in sham and remained elevated in RYGB and 
weight-match groups compared to chow groups. Interestingly, expression of MCFA receptor GPR40 
significantly increased in the RYGB group compared to chow and sham groups, while GPR84 
expression increased significantly compared to all groups (Figure 2C,D). Expression of GPR120, a 
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matched controls compared to the RYGB and chow groups (Figure 2E). Importantly, expression of 
GPR119, which is expressed on L-cells, was significantly increased following RYGB compared to all 
other groups (Figure 2F). GPR119 releases GLP-1 following stimulation and is therefore important 
for insulin regulation in addition to appetite regulation. Similarly, bile acid receptor TGR5 expression 
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Figure 1. mRNA expression levels in chow (lean) vs. sham (obese) of short-chain fatty acid receptors
GPR41 and GPR43 (A,B), medium-chain fatty acid receptors GPR40, GPR84 and GPR120 (C–E),
lipid amide sensor GPR119 (F), amino acid-sensing receptors GPR93 and T1R3 (G,H), bile acid sensor
TGR5 (I), and sodium-glucose co-transporter SGLT1 (J). The expression is described relative to 18s and
represents N = 5–7. Error bars show SEM, and significance is p < 0.05 as denoted by *.
3.2. RYGB Further Up-Regulates Expression of Specific Nutrient-Sensing Receptors
Given the reduced food intake and body weight after RYGB, it is generally thought that it reverses
obesity-induced impairment of intestinal nutrient sensing, but it is not clear whether this happens at
the level of the nutrient-sensing receptor or downstream of the receptor. Our data show that most of the
nutrient-sensing receptors are further up-regulated after RYGB. Importantly, this further up-regulation
was specific to RYGB, but not for similar weight loss induced by calorie restriction. The expression of
SCFA receptor GPR41 as significantly increased in the RYGB group compared to chow (lean) and
sham operation (obese) (Figure 2 ). However, mRNA expression of GPR43, another SCFA sensing
receptor, increased in sham and remained elevated in RYGB and weight-match groups compared
to chow groups. Interestingly, expression of MCFA receptor GPR40 significantly increased in the
RYGB group compared to chow and sham groups, while GPR84 expression increased significantly
compared to all groups (Figure 2C,D). Expression of GPR120, a sensor of omega-3 fatty acids, did not
change after RYGB, but significantly increased in weight-matched controls compared to the RYGB
and chow groups (Figure 2E). Importantly, expression of GPR119, which is expressed on L-cells,
was significantly increased following RYGB compared to all other groups (Figure 2F). GPR119 releases
GLP-1 following stimulation and is therefore important for insulin regulation in addition to appetite
regulation. Similarly, bile acid receptor TGR5 expression was increased in RYGB compared to all
other groups (Figure 2G). However, mRNA expression of the amino acid-sensing receptors GPR92/93
and T1R3 was not significantly altered in response to diet, RYGB or calorie restriction (Figure 2E,F).
Similarly, expression of the glucose transporter SGLT1 was not altered (Figure 2G).
Nutrients 2018, 10, 1529 6 of 13
Nutrients 2018, 10, x FOR PEER REVIEW  6 of 13 
 
 
Figure 2. Altered colonic mRNA expression in obesity, Roux-en Y gastric bypass surgery (RYGB) of 
nutrient-sensing receptors for short-chain fatty acid receptors GPR41 and GPR43 (A,B), medium-
chain fatty acid receptors GPR40, GPR84 and GPR120 (C–E), lipid amide sensor GPR119 (F), amino 
acid-sensing receptors GPR93 and T1R3 (G,H), bile acid sensor TGR5 (I), and sodium-glucose 
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3.3. mRNA Expression of Appetite Modulation Hormones/Peptides Increases in Obesity and RYGB Both
Increase Colonic L-Cell and EC Cell Numbers
mRNA expression of glucagon (the precursor to GLP-1 protein), PYY, and TPH-1 (the precursor
enzyme critical for 5-HT production) was increased but did not reach statistical significance in the
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obese (sham-operated) group (Figure 3A–C). Expression levels decreased in response to RYGB to levels
comparable to lean mice (Figure 3A–C). Protein expression was studied specifically with antibodies
against GLP-1 to label L-cells and against 5-HT to label for EC cells in chow, sham-operated (obese),
and RYGB groups. L-cells stained with GLP-1 showed no difference in numbers between lean and
sham (obese) groups. However, there was a significant increase in RYGB mice compared to both
sham-operated (obese) and chow controls (Figure 3D). Numbers of EC-cells increased as a result of
obesity in the sham group compared to the chow group (Figure 3E). RYGB treatment appeared to
further increase EC cells compared to the sham-operated (obese) group, although this did not reach
statistical significance (Figure 3E).
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3.4. Mucosal Innervation Is Unaltered by Diet and RYGB 
Since changes were observed in the sensory apparatus in terms of expression of nutrient-sensing 
receptors and EECs, we wanted to know if downstream elements in nutrient sensing also adapted 
after diet and RYGB intervention. We used the pan-neuronal marker PGP9.5 to explore overall 
neuronal density in the colonic epithelium and found that there was no change in the number of 
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Figure 3. Col nic mRN ressions of glucagon (th precursor to GLP-1), PYY, and TPH-1
(the enzy e required for 5-HT production) are elevated in sham and weight-match groups, but do not
reach statistical significance (A–C). However, protein staining for GLP-1 show that RYGB significantly
increases the number of GLP-1 containing L-cells compared to chow and sham groups (D). The number
of 5-HT-containing EC cells increases in both sham and RYGB groups compared to chow groups (E).
N = 5–7. Error bars show SEM, and significance is p < 0.05 as denoted by *. The scale bar = 5 µm.
3.4. Mucosal Innervation Is Unaltered by Diet and RYGB
Since changes were observed in the sensory apparatus in terms of expression of nutrient-sensing
receptors and EECs, we wanted to know if downstream elements in nutrient sensing also adapted after
diet nd RYGB intervention. We used the pan-n uro al marker PGP9.5 to explore overall neuronal
density in the colonic epithelium and found th t there was no change in the number of PGP9.5-positive
pixels between chow, sham-op rated, and RYGB groups, with consistent patter of euronal staining
between colonic crypts observed (Figure 4A). We then looked at GLP-1R to see if an altered luminal
environment could specifically affect the mucosal expression of this receptor, which is known to be
localized on vagal afferents [14]. Positive staining was observed around crypts and in close apposition
to the basal side of colonocytes. However, image analysis revealed no differences in pixel number or
expression patterns between the three groups (Figure 4B).
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Figure 4. Expression of pan-neuronal mar er PGP9.5 (green) is unchanged between chow, sham,
and RYGB groups, as demonstrated by im s howing consistent neuronal expressio surrounding
mucosal crypts (A). Quantification of PGP9.5 immunoreactivity (IR) in colonic mucosa showed no
difference in the number of positive pixels between the three groups (B). GLP-1 receptor expression
was found in close apposition to the basal end of colonocytes (red), and quantification of pixels showed
no change in IR between the groups. N = 5–7. The error bars show SEM, and the scale bar = 10 µm.
3.5. Mucosal Stimul tion wi h Specific Nutrients Activa olonocytes
Data from the mRNA expression studies revealed that specific nutrient-sensing GPCRs were
upregulated in obesity and further increased after RYGB treatment. Since these GPCRs are involved
in EEC and EC activation, i foll ws that they m y be involved in mechanisms reducing appetite
and food intake by activating, for example, L-cells and EC cells, thus enabling release of anorectic
hormones/peptides. We specifically chose GPR119, GPR84, GPR40, and TGR5 to use as a combined
stimulus since these receptors were up-regulated in obesity and RYGB, and as GPR119 and GPR40
have been shown to exhibit synergistic effects on GLP-1 secretion [15]. Following 20 in of stimulation
with combined agonists, the number of pERK and pCamKII-expressing cells significantly increased
(Figure 5A,B), confirming the functional validity of the targets we chose for molecular analysis in the
main part of this study.Nutrients 2018, 10, x FOR PEER REVIEW  9 of 13 
 
 
Figure 5. Stimulation of colonic mucosa with GPR84 agonist lauric acid (25 mmol/L), GPR119 agonist 
PSN 375963 (10 μM), GPR40 agonist AS 2034178 (10 μM), and TGR5 agonist TS-G 1005 (10 nM) 
activates both pERK and pCamKII intracellular pathways, as shown by a significant increase in the 
number of IR cells (A,B). Both pERK and pCamKII IR cells were commonly observed to be the most 
superficial cells, with cells within crypts sparsely stained (A,B). N = 3. The error bars show SEM, and 
significance is p < 0.05 as denoted by *. The scale bar = 10 μm. 
4. Discussion 
Our data show that nutrient-sensing GPCRs respond in specific patterns to obesity and RYGB. 
Somewhat unexpectedly, there was a strong general trend for nutrient-sensing receptor expression 
to be up-regulated in the high-fat-fed obese (sham-operated) vs. chow-fed lean mice, although this 
did not reach statistical significance for some GPCRs. This was unexpected because there is 
considerable support for the notion that nutrient-sensing mechanisms are blunted or impaired in 
obesity [16,17]. One explanation for up- rather than down-regulation of nutrient receptors is that, at 
least in the colon, the system adapts to blunted nutrient sensing by up-regulation at the nutrient 
receptor mRNA level, and that obesity-induced impairment of the colonic nutrient-sensing signal 
must be further downstream. There are no other studies on expression levels of nutrient receptors in 
the colon, but a study in overweight and obese humans shows that GPR40, GPR120, and GPR119 
mRNA expression levels in the duodenum are unchanged compared to lean controls [18]. Therefore, 
changes are more distal or are only evoked by a specific dietary intervention, such as in a high-fat 
diet. 
Additional analyses will be necessary to investigate receptor coupling to hormone secretion and 
vagal afferent detection in the colon, and to extend our findings to the upper parts of the GI tract. 
Because RYGB almost completely reverses obesity, it could also be expected to reverse increased 
expression of nutrient-sensing receptors associated with obesity. This was the case for long-chain 
fatty acid receptor GPR120, which RYGB reduced to the level of chow-fed lean controls. The fact that 
this reversal was only seen after RYGB but not weight-matching suggests that it is mediated by a 
weight-loss-specific effect, independent of the surgery. However, this was clearly not the case for 
GPR 41, 40, 84, and 119, which were further enhanced 12 weeks after RYGB as compared to the sham-
surgery group, again suggesting that increased expression is caused by the high-fat diet rather than 
the obese state. 
The observation that expression of MCFAs, lipid sensors, and bile acid-sensing receptors 
changes following RYGB suggests that exposure of previously naïve GPCRs to their nutrient agonists 
Control Treatment 
Control Treatment 
A
B
ntrol Treatment 
ontrol Treatment 
Figure 5. Stimulation of col nic mucosa with GP agonist lauric acid (25 mmol/L), GPR119 agonist
PSN 375963 (10 µM), GPR40 agonist AS 2034178 (10 µM), and TGR5 agonist TS-G 1005 (10 nM) activates
both pERK and pCamKII intracellular pathways, as shown by a significant increase in the number of
IR cells (A,B). Both pERK and pCamKII IR cells were commonly observed to be the most superficial
cells, with cells with n crypts spars ly stained (A,B). N = 3. The error bars show SEM, and significance
is p < 0.05 as denoted by *. The scale bar = 10 µm.
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4. Discussion
Our data show that nutrient-sensing GPCRs respond in specific patterns to obesity and RYGB.
Somewhat unexpectedly, there was a strong general trend for nutrient-sensing receptor expression to
be up-regulated in the high-fat-fed obese (sham-operated) vs. chow-fed lean mice, although this did
not reach statistical significance for some GPCRs. This was unexpected because there is considerable
support for the notion that nutrient-sensing mechanisms are blunted or impaired in obesity [16,17].
One explanation for up- rather than down-regulation of nutrient receptors is that, at least in the
colon, the system adapts to blunted nutrient sensing by up-regulation at the nutrient receptor mRNA
level, and that obesity-induced impairment of the colonic nutrient-sensing signal must be further
downstream. There are no other studies on expression levels of nutrient receptors in the colon, but a
study in overweight and obese humans shows that GPR40, GPR120, and GPR119 mRNA expression
levels in the duodenum are unchanged compared to lean controls [18]. Therefore, changes are more
distal or are only evoked by a specific dietary intervention, such as in a high-fat diet.
Additional analyses will be necessary to investigate receptor coupling to hormone secretion and
vagal afferent detection in the colon, and to extend our findings to the upper parts of the GI tract.
Because RYGB almost completely reverses obesity, it could also be expected to reverse increased
expression of nutrient-sensing receptors associated with obesity. This was the case for long-chain
fatty acid receptor GPR120, which RYGB reduced to the level of chow-fed lean controls. The fact
that this reversal was only seen after RYGB but not weight-matching suggests that it is mediated
by a weight-loss-specific effect, independent of the surgery. However, this was clearly not the case
for GPR 41, 40, 84, and 119, which were further enhanced 12 weeks after RYGB as compared to the
sham-surgery group, again suggesting that increased expression is caused by the high-fat diet rather
than the obese state.
The observation that expression of MCFAs, lipid sensors, and bile acid-sensing receptors changes
following RYGB suggests that exposure of previously naïve GPCRs to their nutrient agonists in
the colon promotes transcription. Increased mRNA expression may result in increased protein
expression of receptors on the surface of EECs and EC cells, which could increase cell activation
and hormone/peptide release. Several studies have shown that GPCR activation can indeed promote
activation of these cells. Examples of GPCR activation include stimulation of GPR40 by small
molecule agonists which promote L-cell activity via release of GLP-1 in diet-induced obese mice [19],
GPR84 activation via endogenous ligand lauric acid releasing GLP-1, PYY, and 5-HT in stimulated
human colonic tissue (ex vivo) [1], synthetic GPR119 agonist increasing GLP-1 levels in L-cells [20]
and obese mice [21], and GPR43 agonists increasing GLP-1 secretion from human cecum (NCI-H716
cells) [22] and primary mouse colonic cultures [23].
We also found mRNA expression of SCFA sensor GPR41 increased after RYGB compared to
the obese group, suggesting that an altered luminal environment can also drive molecular changes.
Colonic mRNA expression of both GPR41 and GPR43 is raised following obesity, as we and others
have shown [24]. RYGB alters the gut microbiome in rats, mice, and humans [25,26], and favors the
growth of Gammaproteobacteria (Escherichia) and Verrucomicrobia (Akkermansia) [26], which is
likely to cause changes to SCFA receptors, especially since Akkermansia municiphilla is associated
with propionate production [27]. Both GPR41 and GPR43 are required for SCFA sensing. However,
no change in GPR43 expression was observed after RYGB, although we did find increased expression
in obesity, as others have described [24]. Protein expression levels may reveal changes, and therefore,
we cannot at this stage conclude that GPR43 expression is not required for RYGB-induced weight loss.
Our finding of elevated TGR5 expression specifically after RYGB, but not after calorie
restriction-induced weight loss, is in agreement with other studies that have shown increased
circulating bile acid levels after bariatric surgery [28]. This finding is likely to be a factor in increased
GLP-1 secretion by TGR5 stimulation [29] after RYGB. However, we have recently demonstrated that
TGR5 signaling is not required for any beneficial effects of RYGB in mice [30], suggesting that bile acid
signaling through FXR may be more important [31].
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It is likely that EEC and EC cells express a range of nutrient-sensing GPCRs at any given time.
The colon has amongst the largest density of EEC and EC cells [32] in the GIT. However, compared
to the number of colonocytes, the number of hormone/peptide releasing cells is low. Therefore, it is
plausible that these cells need to express on their cell surface a variety of receptors to effectively
respond to the variety of nutrient components found in diets. Our use of multiple GPCR agonist
stimulation was to test the capability of normal mouse colonocytes to respond to agonists of GPCRs that
were elevated in the RYGB group. We found that the majority of superficial colonocytes, most highly
exposed to stimulation in Ussing chambers, were activated as demonstrated by pERK and pCamKii
staining. Our data suggest further studies using GPCR agonist stimulation may be able to recapitulate
the effects of RYGB by activating EEC and EC cells.
Increased expression of both L-cells and EC cells has been described in rat models of RYGB.
We and others have shown that hyperplasia resulting from RYGB increases the number but not
the density of EECs (L-cells, I-cells, and N-cells) and EC cells in the Roux and common limbs [33],
alimentary channel [34], and terminal ileum [35]. Data from this study showing L-cell numbers increase
in the colon following RYGB are consistent with these findings. We also found a trend for increased
L-cell numbers in colons of obese vs. lean mice, although statistical significance was not reached.
Nevertheless, these data follow the trend of increased L-cell density following lipid-rich diets in both
humans and mice [36]. Therefore, the plasticity we report in nutrient-sensing GPCRs expression
may drive not only enhanced cell activation, but also cell differentiation. Colonic EC cell numbers
were significantly increased in the obese group of this study, confirming increased 5-HT content and
TPH1/2 mRNA expression in long-term diet-induced obesity (DIO) mice [37]. We do not see any
further increase in EC cell number following RYGB, suggesting that obesity induces maximal EC cell
differentiation. However, it is clear that nutrient load and content have a significant influence on EEC
and EC cell density, which may be attributed to specific GPCRs (and therefore specific nutrients) which
can optimally enhance EEC and EC cell numbers and hormone/peptide release.
Our finding that overall innervation of the colonic mucosa is unchanged in obesity and RYGB
reflects what has been demonstrated for vagal afferent innervation after RYGB in other parts of
the GIT [38]. Unchanged GLP-1R expression in colonic mucosa agrees with our previous work as
well as others showing GLP-1R is not required for the beneficial effects of RYGB [39,40]. However,
GLP-1 acting on GLP-1R expressed on pancreatic β-cells is required for partial improvement of glucose
tolerance after RYGB in mice [41].
Overall, our study demonstrates for the first time that expression of nutrient receptors,
and numbers of GLP-1 containing L-cells and 5-HT cells, are significantly and specifically affected
by high-fat, diet-induced obesity and RYGB. In particular, we report that expression of specific
nutrient-sensing GPCRs is up-regulated by both obesity and even more robustly by RYGB, suggesting
that these receptors may drive EEC and EC cell differentiation, as well as activation. Indeed,
we confirmed that stimulation with agonists (for these GPCRs) does cause cell activation, suggesting
these receptors may be a non-surgical means of enhancing the release of anorectic hormones/peptides.
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